Abstract
Leukoregulin is a 32 kDa glycoprotein cytokine secreted by lymphocytes and monocytes which possesses unique regulatory activities for tumor cells and for cells undergoing transformation to the neoplastic state [1, 2]. These anticancer actions include (a) prevention of chemical carcinogen and radiation-induced transformation, (b) inhibition of neoplastic cell proliferation, (c) increased plasma membrane permeability associated with enhancement of target cell sensitivity to natural killer cell cytotoxicity, and (d) lysis of neoplastic cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ransom JH, Evans CH, McCabe RP, Pomato N, Heinbaugh JA, Chin M, Hanna MG Jr (1985) Leukoregulin, a direct-acting anti-cancer immunologic hormone that is distinct from lymphotoxin and interferon. Cancer Res 45:851–862
Evans CH (1988) Mechanisms of leukoregulin anti-cancer action. In:Ransom JH, Ortaldo J (eds) Leukolysins and cancer:biological and chemical Aspects Humana, Clifton, pp 198–216
Evans CH, Ransom JH (1984) The anti-cancer action of lymphotoxin. In:Goldstein AL (ed) Thymic hormones and lymphokines Plenum, New York, pp 357–364
Cleveland L, Ransom JH, Evans CH (1984). Leukoregulin, a new anticancer lymphokine distinct from lymphotoxin and interferon. Fed Proc 43:1931
Evans CH (1984) Rapid flow cytometric quantitation of leukoregulin, the dominant direct acting anti-tumor lymphokine in lymphotoxin preparations. Fed Proc 43:1970
Evans CH (1982) Lymphotoxin — an immunologic hormone with anticarcinogen and antitumor activity. Cancer Immunol Immunother 12:181–190
Barnett SC, Evans CH (1986) Leukoregulin increased plasma membrane permeability and associated ionic fluxes. Cancer Res 46:2686–2692
Evans CH, Wilson AC, Gelleri BA (1989). Preparative isoelectric focusing in ampholine electrofocusing columns versus immobiline polyacrylamide gel for the purification of biologically active leukoregulin. Anal Biochem 177:358–363
Evans CH, Heinbaugh JA, Ransom JH (1987) Flow cytometric evaluation of leukoregulin as an intrinsic molecular mediator of natural killer lymphocyte cytotoxicity. Lymphokine Res 6:277–297
Ransom JH, Evans CH (1982) Lymphotoxin enhances the susceptibility of neoplastic and preneoplastic cells to natural killer cell mediated destruction. Int J Cancer 29:451–458
Furbert-Harris P, Evans CH (1989) Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity. Cancer Immunol Immunother 30:1314–1317
Trinchieri G, Santoli D (1978) Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 147:1314–1317
Ortaldo JR, Ransom JH, Herberman RB, Sayres TJ (1986). Analysis of cytostatic/cytotoxic lymphokines:relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. J Immunol 137:2857–2863
Merchant RE, Ransom JH, Young HF (1986) Leukoregulin inhibits the growth of human glioblastoma in vitro. J Neuroimmunol 13:31–45
Sheehy PA, Barnett SC, Evans CH, Barker JL (1988). Activation of ion channels in tumor cells by leukoregulin, a cytostatic lymphokine. JNCI 80:868–871
Barnett SC, Evans CH (1988) Leukoregulin induced translocation of protein kinase C activity in K562 cells. Clin Exp Immunol 73:505–509
Evans CH, Baker PD (1988) Tumor-inhibitory antibiotic uptake facilitated by leukoregulin:a new approach to drug delivery. JNCI 80:861–864
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Evans, C.H., Baker, P.D. (1990). Leukoregulin Enhancement of Tumor Inhibitory Drug Uptake. In: Freund, M., Link, H., Welte, K. (eds) Cytokines in Hemopoiesis, Oncology, and AIDS. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75510-1_45
Download citation
DOI: https://doi.org/10.1007/978-3-642-75510-1_45
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52281-2
Online ISBN: 978-3-642-75510-1
eBook Packages: Springer Book Archive